|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 29th, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
158.00
|
158.00
|
3.50
|
3.80
|
3.00
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 04:50PM
|
Aug 29th, 2022 04:50PM
|
Eisai
|
|
|
|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 28th, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
158.00
|
158.00
|
3.50
|
3.80
|
3.00
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 11:50AM
|
Aug 28th, 2022 11:50AM
|
Eisai
|
|
|
|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 27th, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
158.00
|
158.00
|
3.50
|
3.80
|
3.00
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 09:26AM
|
Aug 27th, 2022 09:26AM
|
Eisai
|
|
|
|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 25th, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
157.00
|
157.00
|
3.50
|
3.80
|
3.10
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 01:49PM
|
Aug 25th, 2022 01:49PM
|
Eisai
|
|
|
|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 23rd, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
157.00
|
157.00
|
3.50
|
3.80
|
3.10
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 03:37PM
|
Aug 23rd, 2022 03:37PM
|
Eisai
|
|
|
|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 21st, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
157.00
|
157.00
|
3.50
|
3.80
|
3.10
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 05:28PM
|
Aug 21st, 2022 05:28PM
|
Eisai
|
|
|
|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 20th, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
157.00
|
157.00
|
3.50
|
3.80
|
3.10
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 07:08PM
|
Aug 20th, 2022 07:08PM
|
Eisai
|
|
|
|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 19th, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
157.00
|
157.00
|
3.50
|
3.80
|
3.10
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 05:23PM
|
Aug 19th, 2022 05:23PM
|
Eisai
|
|
|
|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 18th, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
157.00
|
157.00
|
3.50
|
3.80
|
3.10
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 10:09AM
|
Aug 18th, 2022 10:09AM
|
Eisai
|
|
|
|
tyo:4523
|
https://www.indeed.com/cmp/eisai
|
Aug 17th, 2022 12:00AM
|
Open
|
Eisai
|
|
Pharmaceutical & Biotechnology
|
At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
We are a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about us, please visit www.eisai.com/US and follow us on Twitter and LinkedIn.
|
RRv1_100M_500M
|
Woodcliff Lake, NJ
|
|
|
|
3.70
|
71.0
|
68.0
|
69.0
|
73.0
|
63.0
|
62.0
|
60.0
|
62.0
|
57.0
|
66.0
|
|
66.0
|
69.0
|
44.0
|
157.00
|
157.00
|
3.50
|
3.80
|
3.10
|
3.20
|
3.70
|
27.00
|
About a week
|
36.00
|
MEDIUM
|
34.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 02:44PM
|
Aug 17th, 2022 02:44PM
|
Eisai
|
|
|